Tapewire

NYSE · USD

ELV

Elevance Health, Inc.

Export transactions ↓
Tapewire entity
2934
SEC CIK
0001156039
Parsed reports
385

Last 12 months

Inside the activity.

4 purchase rows · 5 sale rows

Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.
Monthly counts
MonthPurchasesSales
Nov 202500
Dec 202500
Jan 202600
Feb 202600
Mar 202612
Apr 202600
May 202601
Jun 202602
Jul 202630
Aug 202600
Sep 202600
Oct 202600

Latest available

Insider transactions

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateOwner / reported roleActivity / securityShares / unitsReported priceReported valueDetails
September 04, 2018 Filed Sep 6, 2018 20:15 UTC
Patel Prakash REVP & President, DBG
GrantEmployee Stock Option (Right to Buy) · Derivative 4,993 $0.00 Strike: $263.70 $0.00
Disclosure

SEC source: 0001127602-18-026873 · form4.xml · derivative · entry 2

Patel Prakash R · CIK 0001751045 · EVP & President, DBG

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 4,993

Underlying: Common Stock · 4,993 shares

Expires 2028-09-04

F2 · derivative.exercise_date: The option represents a right to purchase a total of 4,993 shares, and is exercisable in three annual installments, with two installments of 1,664 shares each and one installment of 1,665 shares, beginning on September 4, 2019, which is the one-year anniversary of the option grant date.

Read SEC document
September 04, 2018 Filed Sep 6, 2018 20:15 UTC
Patel Prakash REVP & President, DBG
GrantCommon Stock 1,186 $0.00 $0.00
Disclosure

SEC source: 0001127602-18-026873 · form4.xml · nonDerivative · entry 1

Patel Prakash R · CIK 0001751045 · EVP & President, DBG

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,186

F1 · shares: Represents restricted share units. Restrictions lapse as follows: 395 shares each on 9/4/2019 and 9/4/2020, and 396 shares on 9/4/2021.

Read SEC document
September 04, 2018 Filed Sep 6, 2018 20:14 UTC
Penczek Ronald WSVP, Chief Accounting Officer
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 357 $0.00 Strike: $166.97 $0.00
Disclosure

SEC source: 0001127602-18-026872 · form4.xml · derivative · entry 5

Penczek Ronald W · CIK 0001659075 · SVP, Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,071

Underlying: Common Stock · 357 shares

Expires 2027-03-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The option represents a right to purchase a total of 2,141 shares, and is exercisable in six semi-annual installments, with one installment of 356 shares and five installments of 357 shares each, beginning on September 1, 2017, which is the six-month anniversary of the option grant date.

Read SEC document
September 04, 2018 Filed Sep 6, 2018 20:14 UTC
Penczek Ronald WSVP, Chief Accounting Officer
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 406 $0.00 Strike: $131.80 $0.00
Disclosure

SEC source: 0001127602-18-026872 · form4.xml · derivative · entry 4

Penczek Ronald W · CIK 0001659075 · SVP, Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 406

Underlying: Common Stock · 406 shares

Expires 2026-03-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · derivative.exercise_date: The option represents a right to purchase a total of 2,432 shares, and is exercisable in six semi-annual installments, with four installments of 405 shares each and two installments of 406 shares each, beginning on September 1, 2016, which is the six-month anniversary of the option grant date.

Read SEC document
September 04, 2018 Filed Sep 6, 2018 20:14 UTC
Penczek Ronald WSVP, Chief Accounting Officer
SaleCommon Stock 763 $265.56 $202,622.28
Disclosure

SEC source: 0001127602-18-026872 · form4.xml · nonDerivative · entry 3

Penczek Ronald W · CIK 0001659075 · SVP, Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 928

Read SEC document
September 04, 2018 Filed Sep 6, 2018 20:14 UTC
Penczek Ronald WSVP, Chief Accounting Officer
Exercise / conversionCommon Stock 357 $166.97 $59,608.29
Disclosure

SEC source: 0001127602-18-026872 · form4.xml · nonDerivative · entry 2

Penczek Ronald W · CIK 0001659075 · SVP, Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,691

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
September 04, 2018 Filed Sep 6, 2018 20:14 UTC
Penczek Ronald WSVP, Chief Accounting Officer
Exercise / conversionCommon Stock 406 $131.80 $53,510.80
Disclosure

SEC source: 0001127602-18-026872 · form4.xml · nonDerivative · entry 1

Penczek Ronald W · CIK 0001659075 · SVP, Chief Accounting Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,334

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
August 27, 2018 Filed Aug 29, 2018 20:42 UTC
Haytaian Peter DEVP & President, Commercial
SaleCommon Stock 968 $266.50 $257,972.00
Disclosure

SEC source: 0001127602-18-026465 · form4.xml · nonDerivative · entry 2

Haytaian Peter D · CIK 0001608538 · EVP & President, Commercial

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 56,706

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 26, 2018.

Read SEC document
August 27, 2018 Filed Aug 29, 2018 20:42 UTC
Haytaian Peter DEVP & President, Commercial
SaleCommon Stock 2,532 $265.70 $672,752.40
Disclosure

SEC source: 0001127602-18-026465 · form4.xml · nonDerivative · entry 1

Haytaian Peter D · CIK 0001608538 · EVP & President, Commercial

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 57,674

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on July 26, 2018.

F2 · price: This transaction was executed in multiple trades at prices ranging from $265.44 to $266.37. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
August 16, 2018 Filed Aug 17, 2018 20:14 UTC
HILL JULIE ADirector
SaleCommon Stock 248 $267.01 $66,218.48
Disclosure

SEC source: 0001127602-18-025677 · form4.xml · nonDerivative · entry 1

HILL JULIE A · CIK 0001243394 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 34,827

Read SEC document
July 26, 2018 Filed Jul 27, 2018 20:19 UTC
Samitt Craig EEVP & President, DBG
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 4,594 $0.00 Strike: $166.97 $0.00
Disclosure

SEC source: 0001127602-18-023949 · form4.xml · derivative · entry 7

Samitt Craig E · CIK 0001601851 · EVP & President, DBG

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,188

Underlying: Common Stock · 4,594 shares

Expires 2027-03-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The option represents a right to purchase a total of 13,782 shares, and is exercisable in six semi-annual installments of 2,297 shares each, beginning on September 1, 2017, which is the six-month anniversary of the option grant date.

Read SEC document
July 26, 2018 Filed Jul 27, 2018 20:19 UTC
Samitt Craig EEVP & President, DBG
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 11,364 $0.00 Strike: $131.80 $0.00
Disclosure

SEC source: 0001127602-18-023949 · form4.xml · derivative · entry 6

Samitt Craig E · CIK 0001601851 · EVP & President, DBG

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,682

Underlying: Common Stock · 11,364 shares

Expires 2026-03-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The option represents a right to purchase a total of 17,046 shares, and is exercisable in six semi-annual installments of 2,841 shares each, beginning on September 1, 2016, which is the six-month anniversary of the option grant date.

Read SEC document
July 26, 2018 Filed Jul 27, 2018 20:19 UTC
Samitt Craig EEVP & President, DBG
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 9,846 $0.00 Strike: $138.94 $0.00
Disclosure

SEC source: 0001127602-18-023949 · form4.xml · derivative · entry 5

Samitt Craig E · CIK 0001601851 · EVP & President, DBG

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,970

Underlying: Common Stock · 9,846 shares

Expires 2025-10-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_date: The option represents a right to purchase a total of 11,816 shares, and is exercisable in four semi-annual installments of 1,969 shares each and two semi-annual installments of 1,970 shares each, beginning on April 1, 2016, which is the six-month anniversary of the option grant date.

Read SEC document
July 26, 2018 Filed Jul 27, 2018 20:19 UTC
Samitt Craig EEVP & President, DBG
SaleCommon Stock 19,541 $246.68 $4,820,373.88
Disclosure

SEC source: 0001127602-18-023949 · form4.xml · nonDerivative · entry 4

Samitt Craig E · CIK 0001601851 · EVP & President, DBG

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 17,274

F1 · price: This transaction was executed in multiple trades at prices ranging from $246.62 to $247.15. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
July 26, 2018 Filed Jul 27, 2018 20:19 UTC
Samitt Craig EEVP & President, DBG
Exercise / conversionCommon Stock 4,594 $166.97 $767,060.18
Disclosure

SEC source: 0001127602-18-023949 · form4.xml · nonDerivative · entry 3

Samitt Craig E · CIK 0001601851 · EVP & President, DBG

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,815

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 26, 2018 Filed Jul 27, 2018 20:19 UTC
Samitt Craig EEVP & President, DBG
Exercise / conversionCommon Stock 11,364 $131.80 $1,497,775.20
Disclosure

SEC source: 0001127602-18-023949 · form4.xml · nonDerivative · entry 2

Samitt Craig E · CIK 0001601851 · EVP & President, DBG

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 32,221

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 26, 2018 Filed Jul 27, 2018 20:19 UTC
Samitt Craig EEVP & President, DBG
Exercise / conversionCommon Stock 9,846 $138.94 $1,368,003.24
Disclosure

SEC source: 0001127602-18-023949 · form4.xml · nonDerivative · entry 1

Samitt Craig E · CIK 0001601851 · EVP & President, DBG

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,857

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
July 02, 2018 Filed Jul 5, 2018 20:16 UTC
Norwood Felicia FExec VP & President, GBD
GrantEmployee Stock Option (Right to Buy) · Derivative 7,516 $0.00 Strike: $238.27 $0.00
Disclosure

SEC source: 0001127602-18-022829 · form4.xml · derivative · entry 2

Norwood Felicia F · CIK 0001743548 · Exec VP & President, GBD

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,516

Underlying: Common Stock · 7,516 shares

Expires 2028-07-02

F2 · derivative.exercise_date: The option represents a right to purchase a total of 7,516 shares, and is exercisable in three annual installments, with two installments of 2,505 shares each and one installment of 2,506 shares, beginning on July 2, 2019, which is the one-year anniversary of the option grant date.

Read SEC document
July 02, 2018 Filed Jul 5, 2018 20:16 UTC
Norwood Felicia FExec VP & President, GBD
GrantCommon Stock 1,784 $0.00 $0.00
Disclosure

SEC source: 0001127602-18-022829 · form4.xml · nonDerivative · entry 1

Norwood Felicia F · CIK 0001743548 · Exec VP & President, GBD

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,784

F1 · shares: Represents restricted share units. Restrictions lapse as follows: 594 shares on 7/2/2019, and 595 shares each on 7/2/2020 and 7/2/2021.

Read SEC document
June 01, 2018 Filed Jun 5, 2018 20:22 UTC
Gallina John EEVP & Chief Financial Officer
Tax withholdingCommon Stock 275 $221.50 $60,912.50
Disclosure

SEC source: 0001127602-18-020019 · form4.xml · nonDerivative · entry 1

Gallina John E · CIK 0001433032 · EVP & Chief Financial Officer

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,659

F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.

Read SEC document
May 25, 2018 Filed May 29, 2018 20:27 UTC
HILL JULIE ADirector
SaleCommon Stock 1,000 $233.00 $233,000.00
Disclosure

SEC source: 0001127602-18-019065 · form4.xml · nonDerivative · entry 1

HILL JULIE A · CIK 0001243394 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 35,075

Read SEC document
May 18, 2018 Filed May 18, 2018 20:18 UTC SaleCommon Stock 1,000 $231.10 $231,100.00
Disclosure

SEC source: 0001127602-18-018128 · form4.xml · nonDerivative · entry 2

Dixon Robert L JR · CIK 0001524849 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 9,738

Read SEC document
May 18, 2018 Filed May 21, 2018 20:10 UTC SaleCommon Stock 2,248 $231.57 $520,569.36
Disclosure

SEC source: 0001127602-18-018271 · form4.xml · nonDerivative · entry 1

PERU RAMIRO G · CIK 0001192045 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 12,076

F1 · kind: The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on March 6, 2018.

Read SEC document
May 16, 2018 Filed May 18, 2018 20:23 UTC GrantCommon Stock 753 $0.00 $0.00
Disclosure

SEC source: 0001127602-18-018136 · form4.xml · nonDerivative · entry 1

Jallal Bahija · CIK 0001730038 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 957

F1 · shares: Phantom Stock units accrued under the Anthem, Inc. ("Company") Board of Directors Compensation Program.

F2 · shares: The phantom stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan.

Read SEC document
May 16, 2018 Filed May 18, 2018 20:21 UTC
HILL JULIE ADirector
GrantCommon Stock 753 $0.00 $0.00
Disclosure

SEC source: 0001127602-18-018133 · form4.xml · nonDerivative · entry 1

HILL JULIE A · CIK 0001243394 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 36,075

F1 · shares: Phantom Stock units accrued under the Anthem, Inc. ("Company") Board of Directors Compensation Program.

F2 · shares: The phantom stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan.

Read SEC document
May 16, 2018 Filed May 18, 2018 20:20 UTC GrantCommon Stock 753 $0.00 $0.00
Disclosure

SEC source: 0001127602-18-018131 · form4.xml · nonDerivative · entry 1

HAY LEWIS III · CIK 0001182705 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,676

F1 · shares: Phantom Stock units accrued under the Anthem, Inc. ("Company") Board of Directors Compensation Program.

F2 · shares: The phantom stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan.

Read SEC document
May 16, 2018 Filed May 18, 2018 20:19 UTC GrantCommon Stock 753 $0.00 $0.00
Disclosure

SEC source: 0001127602-18-018129 · form4.xml · nonDerivative · entry 1

Tallett Elizabeth E · CIK 0001192460 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 7,061

F1 · shares: Phantom Stock units accrued under the Anthem, Inc. ("Company") Board of Directors Compensation Program.

F2 · shares: The phantom stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan.

Read SEC document
May 16, 2018 Filed May 18, 2018 20:17 UTC GrantCommon Stock 753 $0.00 $0.00
Disclosure

SEC source: 0001127602-18-018127 · form4.xml · nonDerivative · entry 1

SCHAEFER GEORGE A JR · CIK 0001195811 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,864

F1 · shares: Phantom Stock units accrued under the Anthem, Inc. ("Company") Board of Directors Compensation Program.

F2 · shares: The phantom stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan.

Read SEC document
May 16, 2018 Filed May 18, 2018 20:18 UTC GrantCommon Stock 753 $0.00 $0.00
Disclosure

SEC source: 0001127602-18-018128 · form4.xml · nonDerivative · entry 1

Dixon Robert L JR · CIK 0001524849 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,738

F1 · shares: Phantom Stock units accrued under the Anthem, Inc. ("Company") Board of Directors Compensation Program.

F2 · shares: The phantom stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan.

Read SEC document
May 16, 2018 Filed May 18, 2018 20:16 UTC GrantCommon Stock 753 $0.00 $0.00
Disclosure

SEC source: 0001127602-18-018125 · form4.xml · nonDerivative · entry 1

PERU RAMIRO G · CIK 0001192045 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 14,324

F1 · shares: Phantom Stock units accrued under the Anthem, Inc. ("Company") Board of Directors Compensation Program.

F2 · shares: The phantom stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan.

Read SEC document
May 16, 2018 Filed May 18, 2018 20:15 UTC GrantCommon Stock 753 $0.00 $0.00
Disclosure

SEC source: 0001127602-18-018124 · form4.xml · nonDerivative · entry 1

CLARK R KERRY · CIK 0001180776 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 5,809

F1 · shares: Phantom Stock units accrued under the Anthem, Inc. ("Company") Board of Directors Compensation Program.

F2 · shares: The phantom stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan.

Read SEC document
May 16, 2018 Filed May 18, 2018 20:15 UTC GrantCommon Stock 753 $0.00 $0.00
Disclosure

SEC source: 0001127602-18-018123 · form4.xml · nonDerivative · entry 1

Neri Antonio F · CIK 0001648401 · Director

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 1,094

F1 · shares: Phantom Stock units accrued under the Anthem, Inc. ("Company") Board of Directors Compensation Program.

F2 · shares: The phantom stock units shall be payable in Company common stock upon the first to occur of (a) five years from the date of grant or (b) the date the Reporting Person ceases to be a member of the Company's board of directors, unless a later date is designated in the Reporting Person's election made under the Company's Board of Directors Deferred Compensation Plan.

Read SEC document
May 03, 2018 Filed May 7, 2018 20:19 UTC
GRIFFIN BRIAN TEVP & CEO, IngenioRx
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 6,636 $0.00 Strike: $166.97 $0.00
Disclosure

SEC source: 0001127602-18-016509 · form4.xml · derivative · entry 17

GRIFFIN BRIAN T · CIK 0001252006 · EVP & CEO, IngenioRx

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 13,272

Underlying: Common Stock · 6,636 shares

Expires 2027-03-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F8 · derivative.exercise_date: The option represents a right to purchase a total of 19,908 shares, and is exercisable in six semi-annual installments of 3,318 shares each, beginning on September 1, 2017, which is the six-month anniversary of the option grant date.

Read SEC document
May 03, 2018 Filed May 7, 2018 20:19 UTC
GRIFFIN BRIAN TEVP & CEO, IngenioRx
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 16,232 $0.00 Strike: $131.80 $0.00
Disclosure

SEC source: 0001127602-18-016509 · form4.xml · derivative · entry 16

GRIFFIN BRIAN T · CIK 0001252006 · EVP & CEO, IngenioRx

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 8,116

Underlying: Common Stock · 16,232 shares

Expires 2026-03-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F7 · derivative.exercise_date: The option represents a right to purchase a total of 24,348 shares, and is exercisable in six semi-annual installments of 4,058 shares each, beginning on September 1, 2016, which is the six-month anniversary of the option grant date.

Read SEC document
May 03, 2018 Filed May 7, 2018 20:19 UTC
GRIFFIN BRIAN TEVP & CEO, IngenioRx
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 4,478 $0.00 Strike: $152.78 $0.00
Disclosure

SEC source: 0001127602-18-016509 · form4.xml · derivative · entry 15

GRIFFIN BRIAN T · CIK 0001252006 · EVP & CEO, IngenioRx

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 896

Underlying: Common Stock · 4,478 shares

Expires 2025-08-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: The option represents a right to purchase a total of 5,374 shares, and is exercisable in six semi-annual installments, with two installments of 895 shares each and four installments of 896 shares each, beginning on February 3, 2016, which is the six-month anniversary of the option grant date.

Read SEC document
May 03, 2018 Filed May 7, 2018 20:19 UTC
GRIFFIN BRIAN TEVP & CEO, IngenioRx
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 14,830 $0.00 Strike: $89.44 $0.00
Disclosure

SEC source: 0001127602-18-016509 · form4.xml · derivative · entry 14

GRIFFIN BRIAN T · CIK 0001252006 · EVP & CEO, IngenioRx

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 14,830 shares

Expires 2021-03-03

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: The option represents a right to purchase a total of 14,830 shares, and is exercisable in six semi-annual installments, with two installments of 2,471 shares each and four installments of 2,472 shares each, beginning on September 3, 2014, which is the six-month anniversary of the option grant date.

Read SEC document
May 03, 2018 Filed May 7, 2018 20:19 UTC
GRIFFIN BRIAN TEVP & CEO, IngenioRx
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 7,489 $0.00 Strike: $146.93 $0.00
Disclosure

SEC source: 0001127602-18-016509 · form4.xml · derivative · entry 13

GRIFFIN BRIAN T · CIK 0001252006 · EVP & CEO, IngenioRx

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 7,489 shares

Expires 2025-03-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The option represents a right to purchase a total of 7,489 shares, and is exercisable in five semi-annual installments of 1,248 shares each and one installment of 1,249 shares, beginning on September 2, 2015, which is the six-month anniversary of the option grant date.

Read SEC document
May 03, 2018 Filed May 7, 2018 20:19 UTC
GRIFFIN BRIAN TEVP & CEO, IngenioRx
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 9,756 $0.00 Strike: $61.88 $0.00
Disclosure

SEC source: 0001127602-18-016509 · form4.xml · derivative · entry 12

GRIFFIN BRIAN T · CIK 0001252006 · EVP & CEO, IngenioRx

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 9,756 shares

Expires 2020-03-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_date: The option represents a right to purchase a total of 9,756 shares, and is exercisable in six semi-annual installments of 1,626 shares each, beginning on September 1, 2013, which is the six-month anniversary of the option grant date.

Read SEC document
May 03, 2018 Filed May 7, 2018 20:19 UTC
GRIFFIN BRIAN TEVP & CEO, IngenioRx
SaleCommon Stock 4,924 $225.35 $1,109,623.40
Disclosure

SEC source: 0001127602-18-016509 · form4.xml · nonDerivative · entry 8

GRIFFIN BRIAN T · CIK 0001252006 · EVP & CEO, IngenioRx

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 15,863

F2 · price: This transaction was executed in multiple trades at prices ranging from $225.15 to $225.49. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
May 03, 2018 Filed May 7, 2018 20:19 UTC
GRIFFIN BRIAN TEVP & CEO, IngenioRx
SaleCommon Stock 54,497 $224.32 $12,224,767.04
Disclosure

SEC source: 0001127602-18-016509 · form4.xml · nonDerivative · entry 7

GRIFFIN BRIAN T · CIK 0001252006 · EVP & CEO, IngenioRx

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 20,787

F1 · price: This transaction was executed in multiple trades at prices ranging from $224.13 to $225.10. The price reported reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected.

Read SEC document
May 03, 2018 Filed May 7, 2018 20:19 UTC
GRIFFIN BRIAN TEVP & CEO, IngenioRx
Exercise / conversionCommon Stock 6,636 $166.97 $1,108,012.92
Disclosure

SEC source: 0001127602-18-016509 · form4.xml · nonDerivative · entry 6

GRIFFIN BRIAN T · CIK 0001252006 · EVP & CEO, IngenioRx

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 75,284

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 03, 2018 Filed May 7, 2018 20:19 UTC
GRIFFIN BRIAN TEVP & CEO, IngenioRx
Exercise / conversionCommon Stock 16,232 $131.80 $2,139,377.60
Disclosure

SEC source: 0001127602-18-016509 · form4.xml · nonDerivative · entry 5

GRIFFIN BRIAN T · CIK 0001252006 · EVP & CEO, IngenioRx

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 68,648

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 03, 2018 Filed May 7, 2018 20:19 UTC
GRIFFIN BRIAN TEVP & CEO, IngenioRx
Exercise / conversionCommon Stock 4,478 $152.78 $684,148.84
Disclosure

SEC source: 0001127602-18-016509 · form4.xml · nonDerivative · entry 4

GRIFFIN BRIAN T · CIK 0001252006 · EVP & CEO, IngenioRx

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 52,416

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 03, 2018 Filed May 7, 2018 20:19 UTC
GRIFFIN BRIAN TEVP & CEO, IngenioRx
Exercise / conversionCommon Stock 14,830 $89.44 $1,326,395.20
Disclosure

SEC source: 0001127602-18-016509 · form4.xml · nonDerivative · entry 3

GRIFFIN BRIAN T · CIK 0001252006 · EVP & CEO, IngenioRx

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 47,938

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 03, 2018 Filed May 7, 2018 20:19 UTC
GRIFFIN BRIAN TEVP & CEO, IngenioRx
Exercise / conversionCommon Stock 7,489 $146.93 $1,100,358.77
Disclosure

SEC source: 0001127602-18-016509 · form4.xml · nonDerivative · entry 2

GRIFFIN BRIAN T · CIK 0001252006 · EVP & CEO, IngenioRx

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 33,108

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
May 03, 2018 Filed May 7, 2018 20:19 UTC
GRIFFIN BRIAN TEVP & CEO, IngenioRx
Exercise / conversionCommon Stock 9,756 $61.88 $603,701.28
Disclosure

SEC source: 0001127602-18-016509 · form4.xml · nonDerivative · entry 1

GRIFFIN BRIAN T · CIK 0001252006 · EVP & CEO, IngenioRx

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 25,619

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

Read SEC document
April 03, 2018 Filed Apr 4, 2018 20:31 UTC
MCCARTHY GLORIA MEVP & Chief Administrative Off
Tax withholdingCommon Stock 184 $227.51 $41,861.84
Disclosure

SEC source: 0001127602-18-014037 · form4.xml · nonDerivative · entry 1

MCCARTHY GLORIA M · CIK 0001203671 · EVP & Chief Administrative Off

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 38,840.1293

F1 · shares: PAYMENT OF TAX LIABILITY BY WITHHOLDING STOCK INCIDENT TO THE VESTING OF PREVIOUSLY GRANTED RESTRICTED STOCK.

Read SEC document
March 13, 2018 Filed Mar 15, 2018 20:30 UTC
ZIELINSKI THOMAS CEVP & General Counsel
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 5,104 $0.00 Strike: $166.97 $0.00
Disclosure

SEC source: 0001127602-18-011705 · form4.xml · derivative · entry 10

ZIELINSKI THOMAS C · CIK 0001234091 · EVP & General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 10,210

Underlying: Common Stock · 5,104 shares

Expires 2027-03-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F6 · derivative.exercise_date: The option represents a right to purchase a total of 15,314 shares, and is exercisable in six semi-annual installments, with four installments of 2,552 shares each and two installments of 2,553 shares each, beginning on September 1, 2017, which is the six-month anniversary of the option grant date.

Read SEC document
March 13, 2018 Filed Mar 15, 2018 20:30 UTC
ZIELINSKI THOMAS CEVP & General Counsel
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 6,763 $0.00 Strike: $131.80 $0.00
Disclosure

SEC source: 0001127602-18-011705 · form4.xml · derivative · entry 9

ZIELINSKI THOMAS C · CIK 0001234091 · EVP & General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 6,764

Underlying: Common Stock · 6,763 shares

Expires 2026-03-01

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F5 · derivative.exercise_date: The option represents a right to purchase a total of 20,289 shares, and is exercisable in six semi-annual installments, with three installments of 3,381 shares each and three installments of 3,382 shares each, beginning on September 1, 2016, which is the six-month anniversary of the option grant date.

Read SEC document
March 13, 2018 Filed Mar 15, 2018 20:30 UTC
ZIELINSKI THOMAS CEVP & General Counsel
Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative 5,588 $0.00 Strike: $146.93 $0.00
Disclosure

SEC source: 0001127602-18-011705 · form4.xml · derivative · entry 8

ZIELINSKI THOMAS C · CIK 0001234091 · EVP & General Counsel

10b5-1 filing: Not disclosed

Ownership: Direct

Disclosed balance after: 0

Underlying: Common Stock · 5,588 shares

Expires 2025-03-02

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_date: The option, representing a right to purchase a total of 16,762 shares and is exercisable in six semi annual installments with two installments of 2,793 shares each and four installments of 2,794 shares each beginning on September 2, 2015, which is the six-month anniversary of the date on which the option was granted.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.